SYNNEX price target raised to $85 from $72 at Brean Capital Brean Capital raised its price target on SYNNEX to $85 following Q4 results. The firm cited solid demand in the core distribution business complemented by impressive growth in the Concentrix business. Shares are Buy rated.
News For SNX From The Last 14 Days
Check below for free stories on SNX the last two weeks.